Single botanical drugs in the Ayurvedic Pharmacopoeia of India-A quantitative ethnobotanical analysis.
Pharmacopoeia
ayurveda
botanical drug
medical flora
quantitative ethnobotany
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2023
2023
Historique:
received:
03
01
2023
accepted:
04
05
2023
medline:
30
5
2023
pubmed:
30
5
2023
entrez:
30
5
2023
Statut:
epublish
Résumé
Developing evidence-based uses of herbal medicines and natural product-based drug discovery are two core aims of ethnopharmacology. This requires an understanding of the medicinal plants and the traditional medical knowledge associated with them which is a basis for cross-cultural comparison. The botanical drugs of traditional medical systems are still not understood well, even for well-known and widely respected traditions like Ayurveda. In this study, a quantitative ethnobotanical analysis was performed on the single botanical drugs included in the Ayurvedic Pharmacopoeia of India (API), presenting an overview on the medicinal plants of Ayurveda from perspectives of plant systematics and medical ethnobotany. Part-I of API includes 621 single botanical drugs, which are sourced from 393 species (323 genera in 115 families). Of these, 96 species yield two or more drugs, together accounting for 238 drugs. Taking the traditional concepts, biomedical uses and the pragmatic disease classification into account, therapeutic uses of these botanical drugs are sorted into 20 categories, which meet primary health demands. The therapeutic uses of the drugs sourced from the same species may differ considerably, but 30 of the 238 drugs are used in highly similar way. The comparative phylogenetic analysis identifies 172 species with high potential for specific therapeutic uses. This medical ethnobotanical assessment for the first time provides a comprehensive understanding on the single botanical drugs in API from the perspective of medical botany using an "etic" (scientist-oriented) approach. This study also highlights the importance of quantitative ethnobotanic methods in understanding traditional medical knowledge.
Identifiants
pubmed: 37251315
doi: 10.3389/fphar.2023.1136446
pii: 1136446
pmc: PMC10213908
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1136446Informations de copyright
Copyright © 2023 Yao, Heinrich, Zhang, Wei, Qi and Gao.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Nat Prod. 2020 Mar 27;83(3):770-803
pubmed: 32162523
Chin Herb Med. 2021 Dec 21;14(1):3-4
pubmed: 36120124
J Tradit Complement Med. 2016 Feb 28;7(1):50-53
pubmed: 28053888
Front Pharmacol. 2021 Jul 16;12:708518
pubmed: 34335270
J Ethnopharmacol. 2015 Nov 4;174:514-9
pubmed: 26342522
J Ethnopharmacol. 2017 Jul 31;207:220-225
pubmed: 28668645
J Ethnopharmacol. 2021 Dec 5;281:114515
pubmed: 34388416
Bioinformatics. 2008 Sep 15;24(18):2098-100
pubmed: 18678590
Chin Herb Med. 2022 Dec 17;15(1):6-14
pubmed: 36875443
J Ethnopharmacol. 2014 Mar 28;152(3):393-402
pubmed: 24374235
J Tradit Complement Med. 2016 Jun 28;7(2):234-244
pubmed: 28417092
Compr Rev Food Sci Food Saf. 2019 Jul;18(4):910-922
pubmed: 33337009
Nucleic Acids Res. 2021 Jul 2;49(W1):W293-W296
pubmed: 33885785
J Evid Based Complementary Altern Med. 2017 Jul;22(3):494-501
pubmed: 27707902
Plant Divers. 2022 Sep 08;45(1):1-5
pubmed: 36876314
Plant Divers. 2022 May 27;44(4):335-339
pubmed: 35967255
J Ethnopharmacol. 2016 Dec 24;194:245-259
pubmed: 27394388
J Ethnopharmacol. 2017 Feb 2;197:32-38
pubmed: 27404231
Nat Rev Drug Discov. 2021 Mar;20(3):200-216
pubmed: 33510482
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15835-40
pubmed: 22984175
Evid Based Complement Alternat Med. 2014;2014:525340
pubmed: 24872833